Cellular and Molecular Immunology · 2019 · 80 citations · 37 references
Life SciencesImmunologyPathologyAutoimmunityImmunoregulationInnate ImmunityB Cell BiologyDendritic Cell BiologyDendritic Cell RegulationDiabetes MellitusInnate Immune Signaling PathwaysT Cell BiologyCd8 Positive T CellsDendritic Cell Tolerogenic FunctionDendritic Cell TolerogenicityDendritic Cell-t Cell InteractionInterleukin-10 Mediated ToleranceRegulatory B Cell FunctionSuppressionType 1 Diabetes Models
Regulatory B cells (Bregs) suppress and reduce autoimmune pathology. However, given the variety of Breg subsets, the role of Bregs in the pathogenesis of type 1 diabetes is still unclear. Here, we dissect this fundamental mechanism. We show that natural protection from type 1 diabetes in nonobese diabetic (NOD) mice is associated with increased numbers of IL-10-producing B cells, while development of type 1 diabetes in NOD mice occurs in animals with compromised IL-10 production by B cells. However, B cells from diabetic mice regain IL-10 function if activated by the innate immune receptor TLR4 and can suppress insulin-specific CD8 T cells in a dendritic cell (DC)-dependent, IL-10-mediated fashion. Suppression of CD8 T cells is reliant on B-cell contact with DCs. This cell contact results in deactivation of DCs, inducing a tolerogenic state, which in turn can regulate pathogenic CD8 T cells. Our findings emphasize the importance of DC-Breg interactions during the development of type 1 diabetes.
37
B cells regulate autoimmunity by provision of IL-10
Simon Fillatreau, Claire H. Sweenie, Mandy J. McGeachy et al. · Nature Immunology · 2002 · 1.6K citations